Barclays
PHVS icon

Barclays’s Pharvaris PHVS Stock Holding History

Barclays’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$716K Buy
20,702
+16,334
+374% +$494K ﹤0.01% 2994
2026
Q1 		$123K Buy
4,368
+1,593
+57% +$42.5K ﹤0.01% 3937
2025
Q4 		$77K Buy
+2,775
New +$66.8K ﹤0.01% 4649
2025
Q3 		– Sell
-2,796
Closed -$49.2K – 5674
2025
Q2 		$49.2K Sell
2,796
-65
-2% -$1.05K ﹤0.01% 4711
2025
Q1 		$44.9K Sell
2,861
-3
-0.1% -$51 ﹤0.01% 4639
2024
Q4 		$54.9K Sell
2,864
-2,836
-50% -$58.4K ﹤0.01% 4744
2024
Q3 		$106K Buy
+5,700
New +$104K ﹤0.01% 4560

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Barclays's PHVS Position: Q2 2026 in Review

Barclays increased its Pharvaris (PHVS) stake by 374% in Q2 2026, buying an estimated $494K and bringing the position to 20,702 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

Barclays first reported a position in PHVS in Q3 2024 and has held it in 7 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Barclays held 20,702 shares of Pharvaris worth $716K as of Q2 2026.
  • Barclays bought 16,334 Pharvaris shares in Q2 2026, an estimated $494K.
  • Pharvaris made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2994 holding.
  • Barclays first reported a position in Pharvaris in Q3 2024 and has held it in 7 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.